Zheng BJ - Search Results

1

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

Ying T, Du L, Ju TW, Prabakaran P, Lau CC, Lu L, Liu Q, Wang L, Feng Y, Wang Y, Zheng BJ, Yuen KY, Jiang S, Dimitrov DS. Ying T, et al. Among authors: zheng bj. J Virol. 2014 Jul;88(14):7796-805. doi: 10.1128/JVI.00912-14. Epub 2014 Apr 30. J Virol. 2014. PMID: 24789777 Free PMC article.

2

Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.

Du L, Zhao G, Chan CC, Sun S, Chen M, Liu Z, Guo H, He Y, Zhou Y, Zheng BJ, Jiang S. Du L, et al. Among authors: zheng bj. Virology. 2009 Oct 10;393(1):144-50. doi: 10.1016/j.virol.2009.07.018. Epub 2009 Aug 15. Virology. 2009. PMID: 19683779 Free PMC article.

3

Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.

Du L, Jin L, Zhao G, Sun S, Li J, Yu H, Li Y, Zheng BJ, Liddington RC, Zhou Y, Jiang S. Du L, et al. Among authors: zheng bj. J Virol. 2013 Feb;87(4):2215-25. doi: 10.1128/JVI.02344-12. Epub 2012 Dec 5. J Virol. 2013. PMID: 23221567 Free PMC article.

4

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development.

Du L, Zhao G, Kou Z, Ma C, Sun S, Poon VK, Lu L, Wang L, Debnath AK, Zheng BJ, Zhou Y, Jiang S. Du L, et al. Among authors: zheng bj. J Virol. 2013 Sep;87(17):9939-42. doi: 10.1128/JVI.01048-13. Epub 2013 Jul 3. J Virol. 2013. PMID: 23824801 Free PMC article.

5

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.

Zhao G, Du L, Ma C, Li Y, Li L, Poon VK, Wang L, Yu F, Zheng BJ, Jiang S, Zhou Y. Zhao G, et al. Among authors: zheng bj. Virol J. 2013 Aug 26;10:266. doi: 10.1186/1743-422X-10-266. Virol J. 2013. PMID: 23978242 Free PMC article.

6

Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines.

Du L, He Y, Wang Y, Zhang H, Ma S, Wong CK, Wu SH, Ng F, Huang JD, Yuen KY, Jiang S, Zhou Y, Zheng BJ. Du L, et al. Among authors: zheng bj. Virology. 2006 Sep 15;353(1):6-16. doi: 10.1016/j.virol.2006.03.049. Epub 2006 Jun 21. Virology. 2006. PMID: 16793110 Free PMC article.

7

Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity.

Du L, Kao RY, Zhou Y, He Y, Zhao G, Wong C, Jiang S, Yuen KY, Jin DY, Zheng BJ. Du L, et al. Among authors: zheng bj. Biochem Biophys Res Commun. 2007 Jul 20;359(1):174-9. doi: 10.1016/j.bbrc.2007.05.092. Epub 2007 May 22. Biochem Biophys Res Commun. 2007. PMID: 17533109 Free PMC article.

8

Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome.

Lau SK, Woo PC, Li KS, Huang Y, Wang M, Lam CS, Xu H, Guo R, Chan KH, Zheng BJ, Yuen KY. Lau SK, et al. Among authors: zheng bj. Virology. 2007 Oct 25;367(2):428-39. doi: 10.1016/j.virol.2007.06.009. Epub 2007 Jul 6. Virology. 2007. PMID: 17617433 Free PMC article.

9

Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.

Du L, Zhao G, Lin Y, Sui H, Chan C, Ma S, He Y, Jiang S, Wu C, Yuen KY, Jin DY, Zhou Y, Zheng BJ. Du L, et al. Among authors: zheng bj. J Immunol. 2008 Jan 15;180(2):948-56. doi: 10.4049/jimmunol.180.2.948. J Immunol. 2008. PMID: 18178835 Free PMC article.

10

Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection.

Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, Wu C, Jin DY, Yuen KY, Zhou Y, Zheng BJ. Du L, et al. Among authors: zheng bj. Vaccine. 2008 Mar 20;26(13):1644-51. doi: 10.1016/j.vaccine.2008.01.025. Epub 2008 Feb 4. Vaccine. 2008. PMID: 18289745 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters